According to the research report titled ‘Cardiac Arrhythmia Monitoring Devices Market Size By Device (Holter Monitor, Event Recorder, Mobile Cardiac Telemetry, Implantable Cardiac Monitor, Electrocardiogram {ECG} Monitor), By Application (Tachycardia {Atrial Tachycardia, Ventricular Tachycardia}, Bradycardia, Premature Contraction), By End-use (Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, The Netherlands, Austria, Finland, Ireland, Lithuania, Luxembourg, Sweden, Denmark, Japan, China, India, Australia, Thailand, Singapore, South Korea, Brazil, Mexico, Chile, Colombia, Ecuador, Peru, Saudi Arabia, South Africa, Kuwait, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, the global cardiac arrhythmia monitoring devices market is expected to be worth USD 8 billion by 2025.
 

According to the report, increasing pervasiveness of cardiovascular disorders is a major factor driving the cardiac arrhythmia monitoring devices market growth. Growing occurrences of various cardiac dysrhythmias including atrial fibrillation, bradycardia, and atrial flutter have augmented the demand for precise heart rhythm monitoring systems, which in turn is stimulating the industry outlook.
 

The market is expected to further expand due to development of innovative solutions by key industry players such as mobile and telemetric cardiac arrythmia monitoring systems. Although the high cost and invasive nature of cardiac arrhythmia monitoring devices may hinder the market growth, availability of favorable reimbursement policies may facilitate the business scenario.
 

As per device type, the report cites that holter monitor device market is expected to grow with a CAGR of 6% during 2019-2025. These devices provide continuous recording and monitoring of heart rhythm during the patient’s daily activities. Holter monitor devices also offer assessment of coronary artery disease, thereby contributing towards the popularity of the device across the globe.
 

Based on the application spectrum, tachycardia application of cardiac arrhythmia monitoring devices is presumed to expand with a CAGR of 6.8% between 2019 and 2025. Rising adoption of sedentary lifestyle coupled with growing demand for tracking tachycardia using cardiac arrythmia monitoring systems will fuel the segmental growth.
 

Citing the end-user landscape, the report states that home settings segment was worth USD 508 million in the year 2018. Shifting preferences towards homecare devices in consort with development of hand-held and portable devices for monitoring heart rhythm are augmenting the demand for such devices in home settings.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2144058/
 

As per regional analysis, U.S. holds approximately 90% share of North cardiac arrhythmia monitoring devices industry. Factors such as growing obese population, high occurrence of cardiovascular diseases, and rising elderly population are key factors fueling the demand for cardiac arrhythmia monitoring devices, hence contributing towards the growth of the market.
 

Spacelabs Healthcare, St. Jude Medical (Abbott Laboratories), Nihon Kohden Corporation, Medtronic Plc, Koninklijke Philips N.V., iRhythm Technologies, GE Healthcare, Biotelemetry, Biotricity, Biotronik, AliveCor, Aurora resurgence and Applied Cardiac Systems are the prominent companies operating in the cardiac arrhythmia monitoring devices market.